2/2
© Reuters. FILE PHOTO: A sign marks the headquarters of the coronavirus disease (COVID-19) vaccine maker Moderna in Cambridge, Massachusetts, U.S., April 28, 2022. REUTERS/Brian Snyder
2/2
© Reuters. FILE PHOTO: A sign marks the headquarters of the coronavirus disease (COVID-19) vaccine maker Moderna in Cambridge, Massachusetts, U.S., April 28, 2022. REUTERS/Brian Snyder
2/2
(Reuters) – Moderna (NASDAQ:) Inc said on Monday it generated about $18.4 billion in COVID-19 vaccine sales in 2022.
Be the first to comment